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Abstract
Background: Prolonged opening of the mitochondrial permeability transition pore (PTP) leads to cell death. Various
ubiquinone analogs have been shown to regulate PTP opening but the outcome of PTP regulation by ubiquinone analogs
on cell fate has not been studied yet.
Methodology/Principal Findings: The effects of ubiquinone 0 (Ub0), ubiquinone 5 (Ub5), ubiquinone 10 (Ub10) and decyl-
ubiquinone (DUb) were studied in freshly isolated rat hepatocytes, cultured rat liver Clone-9 cells and cancerous rat liver
MH1C1 cells. PTP regulation by ubiquinones differed significantly in permeabilized Clone-9 and MH1C1 cells from that
previously reported in liver mitochondria. Ub0 inhibited PTP opening in isolated hepatocytes and Clone-9 cells, whereas it
induced PTP opening in MH1C1 cells. Ub5 did not affect PTP opening in isolated hepatocytes and MH1C1 cells, but it
induced PTP opening in Clone-9 cells. Ub10 regulated PTP in isolated hepatocytes, whereas it did not affect PTP opening in
Clone-9 and MH1C1 cells. Only DUb displayed the same effect on PTP regulation in the three hepatocyte lines tested.
Despite such modifications in PTP regulation, competition between ubiquinones still occurred in Clone-9 and MH1C1 cells.
As expected, Ub5 induced a PTP-dependent cell death in Clone-9, while it did not affect MH1C1 cell viability. Ub0 induced a
PTP-dependent cell death in MH1C1 cells, but was also slightly cytotoxic in Clone-9 by an oxidative stress-dependent
mechanism.
Conclusions/Significance: We found that various ubiquinone analogs regulate PTP in different ways depending on the cell
studied. We took advantage of this unique property to develop a PTP opening-targeted strategy that leads to cell death
specifically in cells where the ubiquinone analog used induces PTP opening, while sparing the cells in which it does not
induce PTP opening.
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Introduction
Mitochondria are involved in several physiological processes
including energy metabolism, calcium homeostasis and pro-
grammed cell death [1,2,3]. Numerous mitochondrial proteins,
which have no pro-apoptotic activity when they remain inside
mitochondria, promote cell death once released into the cytosol
[4]. Both extra-mitochondrial and intra-mitochondrial signaling
pathways can trigger the release of the mitochondrial pro-
apoptotic proteins [2].
The mitochondrial permeability transition consists of a sudden
non-specific increase in the permeability of the inner membrane
[5,6]. A prolonged mitochondrial permeability transition results in
a drastic ATP synthesis inhibition through the collapse of the
proton-motive force, a dramatic increase in ROS production and
the release of the mitochondrial pro-apoptotic proteins [7,8,9].
Permeability transition is due to the opening of an inner
membrane channel [10]: the Permeability Transition Pore (PTP).
Matrix Ca
2+ is the single most important factor for PTP
opening. The amount of matrix Ca
2+ required to open the pore is
modulated by a number of factors. The ‘‘PTP-inhibitors’’ and the
other so-called ‘‘PTP-inducers’’ designate factors that increase and
decrease the amount of Ca
2+ required to induce PTP opening [6].
Cyclosporin A (CsA) is the reference PTP inhibitor. It inhibits PTP
opening by detaching Cyclophilin D (CyP-D) from the other
components of the pore [11].
In primary and cultured cells, several drugs known to inhibit
PTP opening also decrease cell death in response to various
cytotoxic insults [12,13,14]. In animal models, the inhibition of
PTP opening by either CsA or genetic ablation of CyP-D provides
strong protection from reperfusion injury [15,16,17]. In humans,
the first clinical trial has recently shown that CsA treatment
PLoS ONE | www.plosone.org 1 July 2010 | Volume 5 | Issue 7 | e11792reduces infarct size after reperfusion of a coronary thrombosis
[18]. These data suggest that PTP inhibition can be beneficial in
particular pathological conditions, most likely through its effect on
cell death. On the other hand, resistance to Doxorubicin has been
shown to be related to PTP inhibition in a human chronic
myelogenous leukemia cell line [19], while hepatocarcinogenesis
with 2-acetylaminofluorene is preceded by PTP inhibition [20].
Thus, PTP inhibition might in some cases hamper cancer
treatments or eventually participate in carcinogenesis.
Because prolonged PTP opening leads to cell death, the PTP
represents a cellular target for the commitment to cell death [21].
Indeed, pharmacological agents used in anti-cancer therapy have
been reported to target the PTP and to induce cell death via PTP
opening [1,21]. Ideally, drugs used for the treatment of
malignancies would be far more toxic for cancer cells than for
normal cells. However, a PTP-targeted drug able to selectively
open the PTP in cancerous cells only remains to be developed.
In a series of experiments conducted with isolated rat liver
mitochondria, we have shown that several ubiquinone analogs
regulate PTP opening [22,23,24,25]. Three functional classes of
quinones were defined, the PTP-inhibitory quinones, the PTP-
inducing quinones and the PTP-inactive quinones that counteract
the effects of both inhibitory and inducing quinones [24,25]. To
date, few studies have reported a preventive effect of ubiquinone
analogs in a model of cell death. DUb, a PTP-inhibitor quinone in
the liver, has been shown to prevent PTP opening-induced cell
death in HL 60 cells [26]. In contrast, although Ub0 is more
potent than CsA at PTP inhibition in liver and skeletal muscle
mitochondria [27], Ub0 was ineffective in preventing PTP
opening-induced cell death in HL 60 cells [26].
To clarify this issue, and because PTP regulation can vary
depending on the tissue studied [27], we have begun a
comprehensive study of PTP regulation in different cell lines.
This work presents the effect of four ubiquinone analogs on three
different rat liver cell lines. We confirm that ubiquinone analogs
regulate PTP opening in the different cells tested. However, we
found that a number of ubiquinone analogs may regulate PTP in
different ways depending on the cell studied. We took advantage of
this unique property to develop a PTP opening-targeted strategy
that leads to cell death specifically in cells where the ubiquinone
analog used induces PTP opening.
Materials and Methods
Cells
Clone-9 and MH1C1 cells are, respectively, non-cancerous and
cancerous rat hepatocyte cell lines. Clone-9 and MH1C1 cells
were maintained in exponential growth phase using Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal bovine
serum for Clone-9, and Ham’s F12K medium supplemented with
2.5% fetal bovine serum and 15% horse serum for MH1C1. Both
media were supplemented with 2 mM glutamine, 1mM sodium
pyruvate, 1% non-essential amino acids, 50 units/ml penicillin,
and 50 mg/ml streptomycin. Hepatocytes were isolated according
to Berry and Friend’s methodology, modified by Groen et al [28].
Ca
2+ retention capacity
Non confluent cultured cells, harvested by trypsinization,
washed with PBS or freshly isolated hepatocytes were permeabi-
lized immediately before use by incubation of 5610
6 cells under
agitation for 2 min at 25uCi naC a
2+ free medium (Chelex resin,
overnight, 4uC) containing 250 mM sucrose, 1 mM Pi-Tris,
10 mM Tris-MOPS (pH 7.4) and 50 mg/ml digitonin. Measure-
ments of Ca
2+ were performed fluorimetrically at 25uC with a PTI
Quantamaster C61 spectrofluorometer equipped with magnetic
stirring and thermostatic controls. Extra-mitochondrial Ca
2+ was
measured in the presence of 1 mM Calcium Green-5N with
excitation and emission wavelengths set at 506 and 530 nm,
respectively. The Ca
2+ uptake and Ca
2+ release of digitonin
permeabilized cells were measured by loading cells with trains of
Ca
2+ pulses at constant time intervals.
ROS production
Cells were incubated in a medium containing 250 mM sucrose,
1 mM Pi-Tris, 10 mM Tris-MOPS, and 5 mMH 2DCFDA.
Measurement of H2DCFDA oxidation were performed fluorime-
trically at 37uC (with excitation and emission wavelengths set at
506 and 521 nm, respectively) with a PTI Quantamaster C61
spectrofluorometer equipped with magnetic stirring and thermo-
static controls.
Cells Staining
Clone-9 cells were labeled with the lipophilic dye PKH26
according to the manufacturer’s instructions. This non-toxic
fluorescent dye binds irreversibly to the cell membrane without
affecting cell growth. Therefore, upon cell division, the probe is
partitioned equally between each daughter cell, but does not
transfer to co-cultured cells [29].
Cells treatment and cell death analysis
Cells were exposed to the indicated concentrations of
ubiquinone analogs for 30 min at 37uC in a serum-free medium.
Cells were then harvested and incubated in a complete medium at
37uC for 24 h. Annexin V-positive cells were quantified by flow
cytometry using a FACSCan flow cytometer (Becton-Dickinson).
Cells (1610
6/ml) were exposed to 5% v/v annexin V-FluoProbes
Alexa 488 for 15 min at room temperature. For each sample, a
minimum of 10,000 events were analyzed.
Reagents
Ub0 (2,3-dimethoxy-5-methyl-1,4-benzoquinone or coenzyme
Q0), Ub5 (2,3-Dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-
benzoquinone or coenzyme Q1), Ub10 (2,3-Dimethoxy-5-methyl-
6-geranyl-1,4-benzoquinone or coenzyme Q2), DUb (2,3-Di-
methoxy-5-methyl-6-decyl-1,4-benzoquinone) and CsA were pur-
chased from Sigma. Calcium Green-5N, H2DCFDA and Annexin
V-FluoProbes Alexa 488 were purchased from Molecular Probes.
Ham’s F12K medium was purchased from Gibco, Fetal Bovine
Serum from Biotech and trypsin from Jacques Boy. The remaining
reagents were purchased from Sigma.
Statistics
Stastistical analyses were performed using two-tailed unpaired
Student’s t tests with equal variances.
Results
The Ca
2+ retention capacity (CRC) represents the minimum
Ca
2+ load required to induce PTP opening in an entire population
of mitochondria. Therefore, CRC measurement represents a
suitable method to quantify and compare the potency of different
PTP regulators. The CRC is measured by loading mitochondria
with train of Ca
2+ pulses until a rapid Ca
2+ release occurs. This
event is accompanied by mitochondrial swelling and membrane
depolarization, and is prevented by CsA [27].
The CRC measurement can be performed equally well in
isolated or in situ mitochondria (i.e. in digitonin permeabilized
cells). However, because PTP regulation may be very sensitive to
Versatile PTP Regulation
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whether PTP regulation by ubiquinone analogs in permeabilized
rat hepatocytes was identical to that previously measured in
isolated rat liver mitochondria.
As shown in Figure 1A, Ub0 a n dD U bi n c r e a s e dt h eC R C
(i.e. inhibited PTP opening) in rat hepatocytes in a concentra-
tion-dependent manner up to an optimal concentration beyond
which Ub0 and DUb became less potent at PTP inhibition.
Ub10 inhibited PTP opening at low concentrations, but
activated PTP opening at high concentration in rat hepatocytes.
Ub5 did not affect PTP regulation in rat hepatocytes. These
results are in total agreement with those previously found with
isolated rat liver mitochondria [23,24,25], indicating that the
model used (i.e. isolated mitochondria or in situ mitochondria)
did not influence the effect of the tested ubiquinone analogs at
PTP regulation.
We next studied the effects of Ub0,U b 5,U b 10 and DUb on the
CRC of two other digitonin permeabilized rat liver cells, namely
cultured rat liver Clone-9 cells and cancerous rat liver MH1C1
cells. As shown in Figure 1, PTP opening in the absence of
ubiquinone analogs occurred at approximately 60, 10 and
25 nmol Ca
2+ per million cells in isolated hepatocytes, Clone-9
and MH1C1, respectively. Such differences in the basal CRC are
expected [31] and may be at least partly related to differences in
Figure 1. The regulation of PTP opening by ubiquinone analogs depends on the cell lines. The incubation medium contained 250 mM
sucrose, 1 mM Pi-Tris, 10 mM Tris-MOPS, 5 mM succinate-Tris, 50 mM digitonin and 1 mM Calcium Green-5N. The final volume was 2 ml, pH 7.4, 25uC.
Experiments were begun by the addition of 5.10
6 cells (isolated rat hepatocytes, MH1C1 or Clone-9) followed by the addition of ubiquinone 0 (Ub0),
ubiquinone 5 (Ub5), ubiquinone 10 (Ub10) or decyl-ubiquinone (DUb) at the indicated concentrations. After 2 min of incubation, the Ca
2+ Retention
Capacity (CRC) was measured by adding Ca
2+ pulses every 90 s until PTP opening. Results are mean 6 S.D. of at least four independent experiments.
doi:10.1371/journal.pone.0011792.g001
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inhibited PTP opening in the three different cell lines (data not
shown).
In immortalized Clone-9 cells (Figure 1B), Ub0 and DUb were
PTP-inhibitors as observed in permeabilized hepatocytes, al-
though the optimal concentration varied with the cell line studied.
Surprisingly, contrary to what occurred in permeabilized hepato-
cytes, Ub5 favored PTP opening, whereas Ub10 was ineffective in
Clone-9 cells. In cancerous rat liver MH1C1 cells (Figure 1C), Ub0
favored PTP opening, Ub5 and Ub10 were ineffective, whereas
DUb inhibited PTP opening. These data indicate that the effects
of ubiquinone analogs on PTP regulation dramatically differed
according to the type of cell used.
In isolated rat liver mitochondria, we have shown that PTP-
inactive quinones were able to counteract the effects of both
inhibitory and inducing quinones, suggesting the existence of a
common site of action for which the ubiquinone analogs
compete [25]. In order to check whether these competitions
persist in cells in which PTP regulation differs from that
observed in liver mitochondria, permeabilized Clone-9 and
MH1C1 cells were exposed to a combination of PTP-active
plus PTP-inactive quinones. Results are presented in Figure 2.
In Clone-9, the PTP-inactive quinone Ub10 was able to
counteract the effect of the PTP- inhibitory Ub0 and of the
PTP-inducing Ub5.S i m i l a r l y ,i nM H 1 C 1 ,t h eP T P - i n a c t i v e
quinone Ub5 was able to counteract the inducing effect of Ub0.
Therefore, despite the fact that PTP regulation by quinone
changes according to the cell studied, this data suggests that the
competition between 3 functionally classes of quinones is a
ubiquitous phenomenon.
Because PTP opening is expected to induce cell death, we next
verified whether the changes observed in PTP regulation were
associated with consecutive changes in cell death regulation. In
other words, we hypothesized that ubiquinone analogs were
capable of inducing cell death selectively in cells in which they
favored PTP opening.
In MH1C1 cells (Figure 3A), PTP-inducer Ub0 induced cell
death in a concentration-dependent manner. Moreover, Ub0-
induced cell death was prevented by PTP-inhibitor DUb
(Figure 3A) and by CsA (not shown), confirming that Ub0-induced
cell death was due to PTP opening in that cell line. As expected,
PTP-inactive Ub5 and PTP-inhibitor DUb did not induce any
significant toxicity.
In Clone-9 cells (Figure 3B), PTP-inducer Ub5 induced cell
death in a concentration-dependent manner. As expected, Ub5-
induced cell death was prevented by PTP-inhibitors DUb
(Figure 3B) and by CsA (not shown). Surprisingly, Ub0 and
DUb, which both inhibited PTP opening in that cell line (see
Figure 1), affected cell viability in a different manner. DUb did not
induce any significant toxicity, whereas Ub0 induced Clone-9 cell
death.
Ubiquinone analogs have been reported to either reduce or
increase reactive oxygen species (ROS) formation [25,26]. In
order to check whether Ub0-induced cell death in Clone-9 was
related to oxidative stress, we next measured H2DCFDA oxidation
(i.e., ROS production) in Clone-9 and MH1C1 cells before and
after the addition of Ub0,U b 5,U b 10 or DUb. As shown in
Figure 4A, Ub0 dramatically increased ROS production in Clone-
9, whereas it slightly decreased ROS production in MH1C1 cells.
Ub5 and Ub10 also acted as pro-oxidants in Clone-9 (although they
were less potent than Ub0), whereas they acted as antioxidants in
MH1C1. Only DUb was antioxidant in the two cell lines.
Confirming that Ub0 toxicity in Clone-9 was due to oxidative
stress, tocopherol or tiron hampered Ub0-induced cell death in
Clone-9 (Figure 4B).
Because Ub5 induced cell death in Clone-9 but not in
MH1C1, we next measured the toxicity of Ub5 in co-cultures of
MH1C1 plus Clone-9 cells. In order to distinguish the two
populations of cells, Clone-9 were labeled with the fluorescent
lipophilic dye PKH-26 before being co-cultured with MH1C1 in
a complete F12K medium. In preliminary experiments, we first
checked that PKH-26 did not affected PTP regulation or cell
viability (data not shown). As shown in Figure 5A, Ub5 induced
cell death in the Clone-9 population, but it spared the MH1C1
population.
Because a same concentration of Ub0 was more cytotoxic in
cells in which it induced PTP opening (i.e. MH1C1) than in cells
where it inhibited PTP opening (i.e. Clone-9), we also measured
Figure 2. Competition between PTP-inactive and PTP-active ubiquinone analogs on PTP regulation in Clone-9 and MH1C1 cells. The
Ca
2+ Retention Capacity was measured as in Fig. 1. When indicated, 20 mMU b 0, 100 mMU b 5 or 100 mMU b 10 were added. The results represent the
means 6 S.D. of three independent experiments. *, p#0.05; **, p#0.01, unpaired Student’s t test.
doi:10.1371/journal.pone.0011792.g002
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As shown in Figure 5B, Ub0 induced cell death in the two
populations but with a higher percentage of cell death in MH1C1
cells.
Discussion
In this work we have shown that several ubiquinone analogs
are able to regulate PTP opening according to the cell type.
Therefore, an important and practical conclusion of this work is
that PTP regulation by ubiquinones is an unpredictable
phenomenon that cannot be extrapolated from results observed
with isolated liver mitochondria. However, this remarkable
property led us to develop a PTP-oriented strategy that allows
a selective death in cells in which the ubiquinone induces PTP
opening, while sparing totally (Ub5 in MH1C1) or partially (Ub0
in Clone-9) the cells in which the ubiquinone does not induce
PTP opening. If every PTP inhibiting ubiquinone did not
necessarily prevent cell death, all the PTP inducing ubiquinones
induced cell death, confirming that PTP opening triggers the cell
suicide program.
Another important finding of this work is that ubiquinone
analogs are able to modulate ROS production in different way
according to the cell type. Note however that within a given cell
line, the way a ubiquinone analog modulates ROS production
does not correlate with the way it regulates PTP opening (compare
Figures 1 and 4). Indeed, ubiquinone analogs can (i) inhibit PTP
opening and stimulate ROS production (Ub0 in Clone-9), (ii) favor
PTP opening and inhibit ROS production (Ub0 in MH1C1 cells),
(iii) favor both PTP opening and ROS production (Ub5 in Clone-
9), (iv) inhibit both PTP opening and ROS production (DUb in
Clone-9 and MH1C1 cells), (v) modify ROS production without
obvious effect on PTP regulation (Ub5 and Ub10 in MH1C1 cells,
Ub10 in Clone-9). Therefore, the effects of the ubiquinone analogs
on ROS production cannot account for the effects on PTP
opening, and vice versa.
Figure 3. Effect of ubiquinone analogs on MH1C1 and Clone-9 viability. MH1C1 and Clone-9 cells were exposed for 30 min to serum-free
culture medium supplemented or not with the indicated concentrations of Ub0 or Ub5 (left and right panels). When used in combination (middle
panels), the concentrations were 20 mM for Ub0,5 0mMU b 5 and 100 mM for DUb. Cells were then incubated in normal medium for 24 h. The
percentage of mortality represents the proportion of Annexin V-positive cells measured by flow cytometry. The results represent the means 6 S.D of
at least four independent experiments. **, p#0.01; ***, p#0.001, unpaired Student’s t test. In preliminary experiments, we found that Annexin V-
positive cells were mostly Propidium iodide positive.
doi:10.1371/journal.pone.0011792.g003
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discovered so far in rat liver mitochondria [27], this work shows
that Ub0 favors PTP opening in MH1C1 cells or induces oxidative
stress in Clone-9 cells. It has been reported that Ub0 was
ineffective in preventing cell death in HL 60 cells [26]. This may
be easily explained hypothesizing that Ub0 may not inhibit PTP
opening or may induce oxidative stress in HL 60 cells.
Some tissue-specificities in PTP regulation have been previously
reported. For example, CsA does not inhibit PTP opening in a
particular line of K562 cell resistant to doxorubicin [19]. The
inhibition of respiratory chain complex 1 inhibits PTP opening in
U937, KB and HMEC cells [31,32,33], whereas it does not have
this effect in rat liver or rat heart mitochondria [6]. However, to
the best of our knowledge, this is the first piece of evidence
showing that a drug can regulate PTP opening in contradictory
ways which are dependent on the cell line.
In previous works conducted with isolated rat liver mitochon-
dria, we proposed that ubiquinone analogs might regulate PTP via
a common site. This hypothesis was sustained by the fact that
inactive quinones were able to counteract the effects of both
inhibitory and inducing quinones. At that time, the biphasic effect
of some quinones (inhibitory at low concentration and inactive or
even activating at high concentration) was explained by hypoth-
esizing (i) that quinones formed aggregates at high concentrations
and (ii) that these aggregates were either inactive or activating
compounds able to compete with the monomeric-inhibiting
quinone.
The observation that the same concentration of ubiquinone
analog can inhibit or activate PTP opening according to the cell
line used no longer supports this model. These data are now more
consistent with another proposed model [25] involving two
regulatory sites: one responsible for inhibition and one for
activation. The occupancy of a site by an active compound
would, in turn, modulate PTP opening through secondary changes
in the PTP Ca
2+ binding affinity, whereas binding by an inactive
compound would not. In this model, the biphasic response
observed with some quinones could easily be explained through
the assumption that these quinones may bind the two sites: the
inhibitory site with high affinity and the inducing site with a lower
affinity.
Because the effect of some ubiquinone analogs depends on the
cell line, we propose that the affinity of these sites for one
particular quinone, as well as the secondary changes in the PTP
Ca
2+ binding affinity, may change according to the cell line.
These changes would depend on genetic or metabolic differences.
Note, however, that the observed changes were not due to
differences in the growth media (Figure 4), and that the CRC
experiments were performed in the same experimental condition
(Figure 1). Therefore, the putative modifications may directly
affect the PTP.
This study constitutes the first report of a PTP-targeted strategy
able to selectively open the PTP and consecutively provoke cell
death in some cells whilst sparing others. Therefore, this work
should be viewed as the first proof of concept suggesting that the
PTP is a key target for selecting cells that will commit the cell
death program. Finding compounds that open PTP in one
cancerous cell line (without any side effect on normal cells) needs
further studies. This will benefit from an improved knowledge of
Figure 4. The effect of ubiquinone analogs on ROS production depends on the cell lines. A - The incubation medium contained 250 mM
sucrose, 1 mM Pi-Tris, 10 mM Tris-MOPS, and 5 mMH 2DCFDA. The final volume was 2 ml, pH 7.4, 37uC. Experiments were begun by the addition of
5.10
6 cells (MH1C1 or Clone-9) followed by the addition of 20mMU b 0, 100mMU b 5, 100mMU b 10 or 100mM DUb. FUb/F0 represents the change in
fluorescence during 5 min after the addition of ubiquinone analog divided by the change in fluorescence during 5 min before the addition of
ubiquinone analog. Results are mean 6 S.D. of at least three independent experiments. B - Clone-9 cells were exposed for 30 min to serum-free
culture media supplemented or not with 20 mMU b 0, 200 mM tocopherol or 1 mM tiron. Cells were then incubated in normal medium for 24 h. The
percentage of mortality represents the proportion of Annexin V-positive cells measured by flow cytometry. The results represent the means 6 S.D of
at least three independent experiments. *, p#0.05; **, p#0.01, unpaired Student’s t test.
doi:10.1371/journal.pone.0011792.g004
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understanding of why PTP-regulation by quinones (and probably
other compounds) changes according to the cell line.
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